Sharon Bio September quarter profit up 23.65 pc at Rs 11.97 cr
Drug firm Sharon Bio-Medicine today said its net profit rose by 23.65 per cent to Rs 11.97 crore for the quarter ended September 30, 2012 on back of robust sales.
By PTI | Updated:
NEW DELHI: Drug firm Sharon Bio-Medicine today said its net profit rose by 23.65 per cent to Rs 11.97 crore for the quarter ended September 30, 2012 on back of robust sales.
The company had posted a net profit of Rs 9.68 crore for the quarter ended September 30, 2011, Sharon Bio-Medicine said in a filing to BSE.
Net sales of the company also rose to Rs 216.68 crore for the quarter under consideration from Rs 174.36 crore in the corresponding period of previous fiscal.
The company manufactures Intermediates, active pharmaceutical ingredients ( APIs) and finished dosages, Sharon Bio-Medicine said.
Shares of Sharon Bio-Medicine today closed at Rs 358 on BSE, down 0.68 per cent from their previous close.
The company had posted a net profit of Rs 9.68 crore for the quarter ended September 30, 2011, Sharon Bio-Medicine said in a filing to BSE.
Net sales of the company also rose to Rs 216.68 crore for the quarter under consideration from Rs 174.36 crore in the corresponding period of previous fiscal.
The company manufactures Intermediates, active pharmaceutical ingredients ( APIs) and finished dosages, Sharon Bio-Medicine said.
Shares of Sharon Bio-Medicine today closed at Rs 358 on BSE, down 0.68 per cent from their previous close.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
Related Articles
Sebi bars 7 entities from market for 3 yrs on insider trading in Sharon Bio-Medicine sharesADVERTISEMENT
